EE04142B1 - Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga - Google Patents

Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga

Info

Publication number
EE04142B1
EE04142B1 EEP200000143A EEP200000143A EE04142B1 EE 04142 B1 EE04142 B1 EE 04142B1 EE P200000143 A EEP200000143 A EE P200000143A EE P200000143 A EEP200000143 A EE P200000143A EE 04142 B1 EE04142 B1 EE 04142B1
Authority
EE
Estonia
Prior art keywords
antagonist
selective
combination
partial agonist
agonist
Prior art date
Application number
EEP200000143A
Other languages
English (en)
Inventor
Berg Stefan
Ross Svante
Thorberg Seth-Olov
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000143A publication Critical patent/EE200000143A/et
Publication of EE04142B1 publication Critical patent/EE04142B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200000143A 1997-09-18 1998-09-09 Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga EE04142B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703374A SE9703374D0 (sv) 1997-09-18 1997-09-18 A new combination
PCT/SE1998/001600 WO1999013876A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (2)

Publication Number Publication Date
EE200000143A EE200000143A (et) 2001-02-15
EE04142B1 true EE04142B1 (et) 2003-10-15

Family

ID=20408294

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000143A EE04142B1 (et) 1997-09-18 1998-09-09 Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga

Country Status (30)

Country Link
US (1) US6159972A (et)
EP (1) EP1021183B1 (et)
JP (1) JP2001516717A (et)
KR (1) KR20010024075A (et)
CN (1) CN1182847C (et)
AR (1) AR015447A1 (et)
AT (1) ATE261728T1 (et)
AU (1) AU752718B2 (et)
BR (1) BR9812234A (et)
CA (1) CA2302383A1 (et)
DE (1) DE69822490T2 (et)
DK (1) DK1021183T3 (et)
EE (1) EE04142B1 (et)
ES (1) ES2216307T3 (et)
HK (1) HK1032740A1 (et)
HU (1) HUP0100401A3 (et)
IL (1) IL134774A0 (et)
IS (1) IS5408A (et)
MY (1) MY116281A (et)
NO (1) NO20001398L (et)
NZ (1) NZ503174A (et)
PL (1) PL339370A1 (et)
PT (1) PT1021183E (et)
RU (1) RU2215528C2 (et)
SE (1) SE9703374D0 (et)
SK (1) SK2842000A3 (et)
TR (1) TR200000734T2 (et)
TW (1) TW568786B (et)
WO (1) WO1999013876A1 (et)
ZA (1) ZA987810B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (en) * 2001-02-21 2002-08-29 Sankyo Company, Limited Chromene derivatives
WO2003007956A1 (en) * 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
USD969017S1 (en) 2021-06-28 2022-11-08 Koninklijke Asscher Diamant Maatschappij B.V. Rose marquise diamond article

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
FI961247A0 (fi) * 1996-03-18 1996-03-18 Finnish Peroxides Ab Oy Foerfarande foer loesning av uppsvaellningsproblem i en avfalls vattenreningsanordning foer kontroll av traodartiga bakterier
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
TR200000734T2 (tr) 2000-11-21
SE9703374D0 (sv) 1997-09-18
MY116281A (en) 2003-12-31
DE69822490D1 (de) 2004-04-22
HK1032740A1 (en) 2001-08-03
AR015447A1 (es) 2001-05-02
BR9812234A (pt) 2000-07-18
ES2216307T3 (es) 2004-10-16
HUP0100401A3 (en) 2003-01-28
EP1021183A1 (en) 2000-07-26
NO20001398D0 (no) 2000-03-17
PT1021183E (pt) 2004-07-30
CN1182847C (zh) 2005-01-05
AU752718B2 (en) 2002-09-26
TW568786B (en) 2004-01-01
WO1999013876A1 (en) 1999-03-25
IL134774A0 (en) 2001-04-30
JP2001516717A (ja) 2001-10-02
EE200000143A (et) 2001-02-15
ATE261728T1 (de) 2004-04-15
EP1021183B1 (en) 2004-03-17
PL339370A1 (en) 2000-12-18
IS5408A (is) 2000-03-15
NO20001398L (no) 2000-04-04
NZ503174A (en) 2002-03-01
DE69822490T2 (de) 2005-03-03
RU2215528C2 (ru) 2003-11-10
CN1279609A (zh) 2001-01-10
ZA987810B (en) 1999-02-18
HUP0100401A2 (hu) 2002-01-28
US6159972A (en) 2000-12-12
AU9192998A (en) 1999-04-05
SK2842000A3 (en) 2000-09-12
KR20010024075A (ko) 2001-03-26
DK1021183T3 (da) 2004-07-05
CA2302383A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
EE200000141A (et) 5-HT tagasihaarde inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga
MX220140B (es) Derivados de benzoilo sustituidos con 3-heterociclilo
DE69734833D1 (de) Vitronektin rezeptor antagonisten
NO980073D0 (no) Brönnsementeringsverktöy med ekspansjonspakning
NO993186D0 (no) Dypvannsstiger°rsystem
EE9700245A (et) 5-HT tagasihaarde inhibiitori kombinatsioon selektiivse 5-HT1A antagonistiga
NO993089D0 (no) Dypvanns-lÕringsinnretning
EE200000146A (et) Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga
DE69506826T2 (de) 5-HT4 Rezeptoragonisten
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
NO994106L (no) Oksazolidiner som 5-HT2A-antagonister
DE59811358D1 (de) Bohrvorrichtung
DE59707375D1 (de) Gesteinsbohrer
DE69919388D1 (de) Elitriptan hydrobromid monohydrat
DE69804639D1 (de) Rohrschneidegerät
DE59708403D1 (de) Dämpfungsring
EE04142B1 (et) Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga
NO993172D0 (no) Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet
DE69800066T2 (de) Marine Antifäulnismittel
SE0702704L (sv) Borrskär
DE59610444D1 (de) Bohrwerkzeug
PT977685E (pt) Ancoras maritimas
DE59906858D1 (de) Fugendübel
DE29716724U1 (de) Bohrgerät
DE29603690U1 (de) Lotgewicht

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

MM4A Lapsed by not paying the annual fees

Effective date: 20050909